About RWE Connect 2026
Empowering Data. Transforming Decisions. Advancing Patient Outcomes.
Real-world evidence (RWE) is revolutionizing how the pharma and life sciences industry designs, develops, and delivers new therapies. RWE Connect 2026, taking place on 14–15 October 2026 in Boston, USA, is where the global RWE community unites to share insights, strategies, and solutions that are redefining the future of evidence generation.
Join industry pioneers, data innovators, regulators, and research leaders as we explore how real-world data can drive smarter trials, accelerate approvals, and shape better health outcomes. From policy to practice — RWE Connect 2026 is your platform to connect, collaborate, and create impact.
Leading the
RWE Revolution
200+
Attendees
40+
Speakers
5+
Industry Partners
Why Boston

Boston is home to one of the world’s most concentrated life sciences clusters, making it the perfect environment for deep scientific and data-driven conversations.

The Greater Boston area hosts hundreds of biopharma HQs, R&D centers, and innovation hubs—ensuring high-quality attendance from industry leaders.

Harvard, MIT, Tufts, and Boston University contribute groundbreaking research, RWD methodologies, and pipelines of emerging scientific talent.

Boston’s renowned hospitals—Mass General Brigham, Dana-Farber, Boston Children’s, and others—provide rich ecosystems for clinical data, real-world evidence, and translational science.

Boston frequently collaborates with regulatory stakeholders, making it an ideal platform for discussions on RWE policy, guidelines, and adoption.

The city’s booming digital health and analytics community fuels advancements in AI, machine learning, and real-world data technologies.

Many leading RWD solution providers, CROs, and analytics companies are headquartered or heavily present in Boston, ensuring strong industry engagement.

Boston’s unique culture fosters partnerships across academia, industry, clinical institutions, and startups—providing fertile ground for RWE collaboration.

With a major international airport and strong transportation links, Boston offers seamless access for U.S. and international attendees.
Connecting the Future of
Real-World Evidence in the U.S.
As a premier Real-World Evidence gathering, RWE Connect convenes decision-makers, innovators, and researchers at the heart of the U.S. life sciences ecosystem—Boston. Explore how leading institutions, biopharma companies, health systems, and technology pioneers across the United States are advancing real-world data, regulatory science, and evidence innovation. Experience the breakthroughs shaping the next generation of RWE, all in one influential venue.
Key Highlights
2 Power-Packed Days in the Heart of Boston
Experience two immersive days designed to spark innovation, foster collaboration, and deliver actionable insights—all set in one of the world’s premier life sciences hubs. Attendees benefit from a concentrated agenda packed with learning, networking, and strategic discussions.
40+ Global Thought Leaders & Visionary Speakers
Hear from an exceptional lineup of experts representing regulators, biopharma, technology innovators, academia, and patient organizations. Each speaker brings unique perspectives on emerging trends, best practices, and the future direction of RWE.
Track Focus: Regulatory, Data & Analytics, and Technology & Innovation
Experience a unified, streamlined track that brings together the most critical aspects of regulatory insights, data science advancements, and emerging technologies. This integrated approach ensures attendees gain a holistic understanding of the evolving evidence-generation landscape, with seamless transitions across key themes that matter most to today’s RWE leaders.
Exclusive Partnering Lounge for 1:1 Meetings
Engage in high-value, private conversations with peers, partners, and potential collaborators. This dedicated space is designed to streamline networking and support strategic business connections in a focused environment.
RWE Innovation Showcase & Poster Zone
Explore cutting-edge research, novel methodologies, and real-world evidence applications presented by industry innovators, startups, and academic teams. Gain inspiration from emerging approaches that are pushing the boundaries of what RWE can achieve.
Exhibition Zone Featuring Leading Solution Providers and Cutting-Edge Technologies
Discover the latest tools, platforms, and services enabling more efficient evidence generation and decision-making. Engage directly with vendors to see demos, explore capabilities, and identify practical solutions to your organizational challenges.
Interactive Panels, Roundtables & Fireside Chats
Participate in dynamic sessions that encourage dialogue, debate, and problem-solving. These formats promote idea exchange and provide opportunities to ask questions, challenge assumptions, and gain new perspectives.
Startup Pavilion Spotlighting Next-Gen RWE Technologies
Meet emerging companies that are reshaping the future of evidence generation with AI-driven analytics, decentralized data infrastructure, automation, and more. See what’s next in the RWE innovation pipeline.
Hands-On Masterclass Workshops
Deepen your expertise through practical, facilitator-led workshops offering step-by-step guidance on advanced RWE methodologies, regulatory documentation, data interoperability, and emerging analytics techniques. Walk away with skills and frameworks you can immediately apply to ongoing projects.
Connect. Influence. Lead.
Market Access & Value Demonstration
Showcase how your solutions help pharma and biotech demonstrate real-world value, support payer negotiations, and enable value-based contracting. Sponsors aligned with this theme are seen as essential partners in commercialization success.

AI & Advanced Analytics Solutions
Highlight cutting-edge analytics, AI, and ML platforms that accelerate evidence generation, reduce development costs, and improve decision-making. Sponsors can demonstrate thought leadership in data-driven innovation.

Data Integration & Interoperability
Emphasize technologies that unify diverse real-world datasets — from EHRs to wearables — helping companies generate actionable insights. Sponsors in this space position themselves as key enablers of high-quality RWE.

Decentralized Trials & Patient-Centric Platforms
Feature solutions that streamline decentralized trials, remote monitoring, and patient engagement, showing sponsors as innovators driving faster, more inclusive clinical studies.

Regulatory & Compliance Enablement
Spotlight tools or services that help sponsors navigate evolving FDA and EMA guidance, ensuring RWE meets regulatory standards. Sponsors aligned here are trusted partners in compliance and risk reduction.

Synthetic Controls & Trial Innovation
Promote technologies that support synthetic control arms or hybrid trial designs, reducing trial timelines and costs. Sponsors gain visibility as enablers of more efficient R&D.

Commercial Intelligence & Real-World Insights
Focus on platforms that turn RWE into actionable commercial strategies, from product positioning to portfolio management. Sponsors are seen as strategic business partners, not just service providers.

Patient Engagement & Digital Health Solutions
Highlight wearables, apps, and patient-reported outcomes tools that capture real-world patient data. Sponsors are positioned as leaders in patient-centric innovation.

Speakers

Naisargi Patel
Data Scientist Regulatory and Real World Evidence
Johnson & Johnson Innovative Medicine

Sarah S
Director, Health Experience and Applied Evidence
Otsuka Precision Health (OPH)

Charles Makin
Head of RWE
Boehringer-Ingelheim

Edgar Simard
Executive Director, Head of Epidemiology & RWD Strategy
Revolution Medicines

Nick Stefanopoulos
Senior Director, Global Digital Health Lead
Pfizer

Ashwini Thirugnanam
PhD Candidate in Pharmacoeconomics
The Massachusetts College of Pharmacy and Health Sciences | Former Real-World Value and Evidence Intern

Tao Fan
Global E&I, Outcomes Research
Merck

Radha Madhavi Ryali
Senior Manager
Novo Nordisk

Anandaroop Dasgupta
Director, Health Economics Outcomes Research (HEOR), Global Value and Access, Oncology
Gilead Sciences

Prajakta Masurkar
Associate Director, US HEOR
UCB

Janie F. Shelton
Director, Translational Epidemiology, Informatics and Predictive Sciences
Bristol Myers Squibb

Nicholas Howard
Health System Medical Outcomes Science Liaison
Alnylam Pharmaceuticals

Dhanish Revanth
HEOR Consultant & Epidemiologist
APPERTURE HEALTH

Mahesh K. Tawney
Director, Strategic Accounts-East
Disc Medicine

Samuel Dyer
CEO
Medical Science Liaison Society

Joseph Anderson
VP. Market Access
Apogee Therapeutics

Jeanne Pierzynski
Associate Director in Real World Evidence Oncology
Gilead Sciences

Neetu Agashivala
Executive Director, Oncology & Immunology HEOR, International
Novartis

Lisa Albert
Director of Epidemiology, RWE Inflammatory Diseases
Gilead Sciences

Trupti Dhumal-Key
HEOR and Bioinformatics Consultant
APPERTURE HEALTH

Tony Okoro
Global Head, Health Economics and Outcomes Research, Pharma
Alcon

Bashir Kalayeh
National Director, Health Economics and Outcomes Research
Bayer
Sponsors & Partners
Who Should Attend
If your work touches real-world data, this is your event.
RWE Connect 2026 brings together

Pharma & Biotech Leaders driving data-informed strategies

Clinical Research, RWE, and HEOR Professionals

Data Science, AI & Analytics Experts

Market Access & Regulatory Affairs Teams

Health Technology Assessment (HTA) Specialists
.webp)
CROs, Consultants & Solution Providers

Policy Makers, Payers, and Healthcare Innovators

Investors and Venture Capitalists focused on Life Sciences Innovation

Medical Affairs Professionals (MSLs, Medical Directors, Insights Leads)
Why Attend
Because RWE is no longer optional — it’s essential.
At RWE Connect 2026, you’ll

Discover breakthrough approaches in RWE design, data integration, and regulatory alignment

Hear from global experts and real-world case studies from top pharma & bio pharma companies

Gain practical insights to strengthen evidence generation and patient engagement strategies

Network with 300+ RWE leaders and innovators shaping tomorrow’s healthcare ecosystem

Explore how AI, digital health, and data interoperability are transforming real-world evidence landscapes

Access exclusive partnering opportunities to forge strategic collaborations and accelerate innovation